DCVC invests in companies applying advanced computing, materials science, and engineering to large industrial sectors, spanning artificial intelligence, exascale computing, climate, robotics, space, water, biology, and defense. Its franchise comprises thirteen funds, and firm materials describe more than 200 portfolio investments. Matt Ocko and Zachary Bogue lead the firm as co-founders and managing partners.
DCVC Bio, the firm's dedicated life-sciences arm, was co-founded by John Hamer, Kiersten Stead, Ocko, and Bogue and operates three funds spanning genetics, chemistry, molecular biology, agriculture, and industrial fermentation. Firm materials describe a team that pairs published scientists and former technology executives with its investment partners, and the firm has published annual Deep Tech Opportunities reports identifying sectors where it expects to deploy.
DCVC - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
